Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aclaris Therapeutics Inc. logo

Aclaris Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.13
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 80 M  90-day average vol: 690,935

Previous close: 1.13  Open: 1.12  Bid: 1.16  Ask: 1.2
52 week range    
0.59   
   11.12
Last updated: Wednesday 19th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

ACRS Income Statement

Annual
Invalid dateDec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock3 M
Amortization of intangibles-31000.0-75000.075000.07 M7 M75000.075000.0
Basic EPS from continuing operations-3.9-1.2-1.6-1.33-1.27
Basic EPS total-3.9-1.2-1.6-1.33-1.27
Basic weighted shares outstanding6 M21 M28 M33 M41 M43 M57 M65 M70 M
BasicDiscontinuousOperations-1.16
Cost of sales-1 M-4 M4 M5 M5 M4 M3 M
Depletion3 M
Depreciation-90000.0-120000.0-370000.0-1 M2 M1 M800000.0700000.0800000.0
Depreciation unreconciled5 M3 M
DepreciationAndAmortization-90000.0-120000.0-370000.0-1 M2 M1 M800000.0700000.0800000.0
DevelopmentExpense4 M
Diluted EPS total-3.79-2.25-2.44-4.03-3.9-1.2-1.6-1.33-1.27
Diluted normalized net income/share-1.6-1.33-1.27
Diluted weighted shares outstanding5 M21 M28 M21 M41 M57 M65 M70 M
DilutedDiscontinuousOperations-1.54
GainOnSaleOfPPE200000.0
GainOnSaleOfSecurity89000.0152000.0678000.0487000.0
GainsLossOnDisposalOfDiscontinuedOperations-552000.01 M139000.0
GeneralAndAdministrativeExpense5 M15 M19 M26 M28 M21 M24 M25 M32 M
Gross operating profit476000.02 M172000.01 M2 M26 M28 M
ImpairmentOfCapitalAssets19 M
Income before tax-21 M-48 M-70 M-82 M-114 M-51 M-91 M-87 M-89 M
Income restructuring and M&A3 M100000.03 M
Income taxes-2 M-182000.0-367000.0
InterestExpenseNonOperating87000.05000.04 M
MiscOtherSpecialCharges104000.0488000.02 M3 M-2 M-424000.0-1 M3 M9 M
Net income from total operations-21 M-48 M-69 M-83 M-161 M-51 M-91 M-87 M-88 M
NetIncomeCommonStockholders-23 M-48 M-69 M-83 M-114 M-51 M-91 M-87 M-88 M
NetIncomeContinuousOperations-21 M-48 M-69 M-83 M-161 M-51 M-91 M-87 M-88 M
NetIncomeDiscontinuousOperations-552000.0-63 M-285000.0
NetNonOperatingInterestIncomeExpense-87000.0-5000.0-4 M
Normalized income-106 M
Operating income-21 M-49 M-72 M-85 M-111 M-51 M-90 M-90 M-97 M
Operating income before depreciation (EBITDA)-20 M-48 M-70 M-80 M-107 M-50 M-90 M-82 M-88 M
OperatingExpense-21 M-49 M-73 M87 M93 M50 M67 M103 M134 M
Other income net-104000.0-488000.0-2 M-3 M7 M3 M25 M2 M-29 M
OtherGainLossFromDispositionOfDiscontinuedOperations14 M424000.0
OtherGandA5 M15 M19 M26 M28 M21 M24 M25 M32 M
OtherImpairmentOfCapitalAssets-289000.0-216000.04 M7 M
OtherOperatingExpenses-21 M-49 M-73 M-139 M1000000.01 M1 M1 M1 M
OtherunderPreferredStockDividend3 M
PreferredStockDividends3 M
PromotionAndAdvertising4 M
RentAndLandingFees5 M15 M19 M26 M
Research & development expense15 M33 M40 M61 M65 M29 M44 M78 M98 M
ResearchExpense15 M33 M40 M61 M65 M29 M44 M78 M98 M
RestructringAndMnAIncome3 M100000.03 M
Revenue per share-31000.0-75000.0518000.07 M7 M75000.075000.0
SalariesAndWages-891000.0-6 M-14 M-17 M
Selling Gen & administrative expense5 M15 M33 M26 M28 M21 M24 M25 M32 M
SellingAndMarketingExpense14 M170000.05 M
SellingExpense14 M170000.0
Special income/charges-19 M-100000.0-3 M
Total Income available for interest expense (EBIT)-21 M-48 M-70 M-82 M-113 M-51 M-91 M-83 M-89 M
Total common shares outstanding20 M26 M31 M41 M42 M52 M67 M71 M
Total net income-21 M-48 M-69 M-83 M-161 M-51 M-91 M-87 M-88 M
Total ordinary shares71 M71 M71 M71 M71 M71 M71 M71 M71 M
Total revenues2 M6 M4 M6 M7 M30 M31 M
TotalExpenses-21 M-49 M-74 M82 M97 M55 M72 M107 M138 M
TotalRevenue2 M6 M4 M6 M7 M30 M31 M
WriteDown5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University